Philip H. Coelho, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 130,000 shares at $15.23 ($2.1M) on 2022-11-21, disclosed to the SEC on 2022-11-23.
Open-market sale of $2.1M CPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.23 | 70,000 | $1.1M | 50.6% |
| 2 | $17.30 | 20,001 | $346K | 16.4% |
| 3 | $17.30 | 20,001 | $346K | 16.4% |
| 4 | $17.45 | 9,999 | $174K | 8.3% |
| 5 | $17.45 | 9,999 | $174K | 8.3% |
| Total | $16.21 avg | 130,000 |
| $2.1M |
| 100% |
| Filing → |
| AMPE | SELL | 2021-05-25 | $13K | — | Filing → |
| AMPE | SELL | 2021-04-29 | $7K | — | Filing → |
| AMPE | SELL | 2021-04-29 | $40K | — | Filing → |